Intellia Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ARK INVESTMENT MANAGEMENT LLC | 05/07/2025 | 13.01 M | $92.51 M | 3.79% | 12.57% |
| VANGUARD GROUP INC | 05/09/2025 | 10.75 M | $76.45 M | 5.52% | 10.39% |
| BLACKROCK, INC. | 05/02/2025 | 10.56 M | $75.05 M | -2.78% | 10.20% |
| STATE STREET CORP | 05/15/2025 | 4.51 M | $32.07 M | -13.36% | 4.36% |
| MORGAN STANLEY | 05/15/2025 | 3.80 M | $27.03 M | -0.34% | 3.67% |
| CAPITAL INTERNATIONAL INVESTORS | 05/12/2025 | 3.78 M | $26.87 M | 100.00% | 3.65% |
| REGENERON PHARMACEUTICALS, INC. | 05/02/2025 | 3.70 M | $26.33 M | 0.00% | 3.58% |
| SUMITOMO MITSUI TRUST HOLDINGS, INC. | 04/25/2025 | 2.83 M | $20.09 M | -5.59% | 2.73% |
| NIKKO ASSET MANAGEMENT AMERICAS, INC. | 05/07/2025 | 2.83 M | $20.00 M | -5.59% | 2.73% |
| CITADEL ADVISORS LLC | 05/15/2025 | 2.76 M | $19.61 M | 10.57% | 2.66% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 2.48 M | $17.64 M | 3.81% | 2.40% |
| GOLDMAN SACHS GROUP INC | 05/16/2025 | 2.41 M | $17.16 M | 18.60% | 2.33% |
| 05/12/2025 | 2.02 M | $14.37 M | 99.73% | 1.95% | |
| CASDIN CAPITAL, LLC | 05/15/2025 | 2.00 M | $14.22 M | 0.00% | 1.93% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2025 | 1.99 M | $14.17 M | 8.09% | 1.93% |
| TWO SIGMA ADVISERS, LP | 05/15/2025 | 1.98 M | $14.09 M | -0.80% | 1.92% |
| DIMENSIONAL FUND ADVISORS LP | 05/13/2025 | 1.97 M | $14.00 M | -0.41% | 1.90% |
| FMR LLC | 05/12/2025 | 1.59 M | $11.31 M | 26.94% | 1.54% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 05/15/2025 | 1.52 M | $10.78 M | -0.75% | 1.46% |
| BALYASNY ASSET MANAGEMENT L.P. | 05/15/2025 | 1.52 M | $10.77 M | -34.31% | 1.46% |
| BANK OF AMERICA CORP /DE/ | 05/15/2025 | 945.58 K | $6.72 M | 47.82% | 0.91% |
| NORTHERN TRUST CORP | 05/13/2025 | 917.76 K | $6.53 M | -6.27% | 0.89% |
| STIFEL FINANCIAL CORP | 05/14/2025 | 789.66 K | $5.61 M | 98.53% | 0.76% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 780.22 K | $5.55 M | -0.92% | 0.75% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 05/14/2025 | 752.68 K | $5.35 M | -23.64% | 0.73% |
| BAKER BROS. ADVISORS LP | 05/15/2025 | 644.12 K | $4.58 M | 0.00% | 0.62% |
| TREXQUANT INVESTMENT LP | 05/14/2025 | 604.70 K | $4.30 M | -9.43% | 0.58% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 586.49 K | $4.17 M | -12.32% | 0.57% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 05/14/2025 | 565.00 K | $4.02 M | 10.29% | 0.55% |
| DISCOVERY VALUE FUND | 05/13/2025 | 561.56 K | $3.99 B | 0.00% | 0.54% |
| JPMORGAN CHASE & CO | 05/12/2025 | 543.63 K | $3.87 M | -2.67% | 0.53% |
| UBS ASSET MANAGEMENT AMERICAS INC | 05/19/2025 | 521.71 K | $3.71 M | 7.97% | 0.50% |
| JUMP FINANCIAL, LLC | 05/14/2025 | 503.81 K | $3.58 M | 38.93% | 0.49% |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 05/15/2025 | 475.95 K | $3.38 M | 55.28% | 0.46% |
| AMERICAN CENTURY COMPANIES INC | 05/13/2025 | 471.68 K | $3.35 M | 3.93% | 0.46% |
| PDT PARTNERS, LLC | 05/15/2025 | 460.25 K | $3.27 M | 40.49% | 0.44% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 429.11 K | $3.05 M | -18.67% | 0.41% |
| SPHERA FUNDS MANAGEMENT LTD. | 05/15/2025 | 381.08 K | $2.71 M | -18.24% | 0.37% |
| ARMISTICE CAPITAL, LLC | 05/15/2025 | 364.00 K | $2.59 M | 100.00% | 0.35% |
| WELLS FARGO & COMPANY/MN | 05/13/2025 | 357.56 K | $2.54 M | 28.76% | 0.35% |
| BNP PARIBAS ARBITRAGE, SNC | 05/14/2025 | 340.46 K | $2.42 M | -22.35% | 0.33% |
| VESTMARK ADVISORY SOLUTIONS, INC. | 05/13/2025 | 311.88 K | $2.22 M | -16.90% | 0.30% |
| CITIGROUP INC | 05/12/2025 | 297.41 K | $2.11 M | 7.39% | 0.29% |
| BANK OF NEW YORK MELLON CORP | 04/29/2025 | 281.94 K | $2.00 M | -0.94% | 0.27% |
| 05/12/2025 | 272.30 K | $1.94 M | 100.00% | 0.26% | |
| VERITION FUND MANAGEMENT LLC | 05/15/2025 | 271.43 K | $1.93 M | 2,327.64% | 0.26% |
| DEUTSCHE BANK AG\ | 05/09/2025 | 251.56 K | $1.79 M | -0.37% | 0.24% |
| RAYMOND JAMES FINANCIAL INC | 05/13/2025 | 249.24 K | $1.77 M | -39.37% | 0.24% |
| BARCLAYS PLC | 05/15/2025 | 240.10 K | $1.71 M | -22.96% | 0.23% |
| CITADEL ADVISORS LLC | 05/15/2025 | 234.50 K | $1.67 M | -20.72% | 0.23% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Intellia Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 387 institutional investors and hedge funds held shares of Intellia Therapeutics, Inc.. The most heavily invested institutionals were:
ARK Investment Management LLC: 13.01 M
VANGUARD GROUP INC: 10.75 M
BlackRock, Inc.: 10.56 M
STATE STREET CORP: 4.51 M
MORGAN STANLEY: 3.8 M
Capital International Investors: 3.78 M
97.80% of Intellia Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 114.85 M shares in the last 24 months. This purchase volume represents approximately $1.05 B in transactions.